| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H |
| P698 | PubMed publication ID | 9303059 |
| P2093 | author name string | J Groves | |
| D L Ball | |||
| L K Webster | |||
| M J Millward | |||
| K Yuen | |||
| M A Joschko | |||
| M Palatsides | |||
| P2860 | cites work | The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer | Q35976361 |
| 5-Fluorouracil radiation sensitization--a brief review | Q38651232 | ||
| Advanced breast cancer: a phase II trial with gemcitabine | Q40435002 | ||
| Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside | Q41276542 | ||
| 2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines | Q41533544 | ||
| The potentiation of radiation response on murine tumor by fludarabine phosphate | Q43603701 | ||
| A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. | Q54027651 | ||
| Apoptosis in Irradiated Murine Tumors | Q60153391 | ||
| Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems | Q68190362 | ||
| Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors | Q71170587 | ||
| Gemcitabine: current status of phase I and II trials | Q72082612 | ||
| Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol | Q72425645 | ||
| Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer | Q72528106 | ||
| Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas | Q72555388 | ||
| P433 | issue | 2 | |
| P921 | main subject | xenograft | Q64148587 |
| tumour xenograft | Q112042499 | ||
| P304 | page(s) | 62-71 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Radiation Oncology Investigations | Q27714266 |
| P1476 | title | Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model | |
| P478 | volume | 5 |
| Q36612113 | Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study |
| Q38796157 | An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines |
| Q40623595 | Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro |
| Q83327743 | Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study |
| Q43991267 | Effect of gemcitabine on acute and late radiation toxicity of skin and underlying soft tissues to single-dose irradiation in a nude mice model |
| Q43736082 | Enhancement of tumor radioresponse by combined chemotherapy in murine hepatocarcinoma |
| Q43960823 | Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? |
| Q78044974 | Maximizing therapeutic gain with gemcitabine and fractionated radiation |
| Q37038352 | Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents |
| Q43812441 | Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer |
| Q33374782 | Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer. |
| Q39414855 | Radiation recall reaction following gemcitabine |
| Q73850903 | Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine) |
| Q28216038 | Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro |
| Q38374871 | Scientific impact of studies published in temporarily available radiation oncology journals: a citation analysis |
| Q44574471 | Selective targeting of homologous DNA recombination repair by gemcitabine |
| Q39956742 | The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro |
| Q44466275 | The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs |
| Q33245149 | The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines |
| Q34371493 | Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer |
Search more.